Update to Interim Guidance for Preexposure Prophylaxis (PrEP) for the Prevention of HIV Infection: PrEP for injecting drug users.
On June 12, 2013, the Thailand Ministry of Health and CDC published results from a randomized controlled trial of a daily oral dose of 300 mg of tenofovir disoproxil fumarate (TDF) that showed efficacy in reducing the acquisition of human immunodeficiency virus (HIV) infection among injecting drug u...
| Published in: | MMWR: Morbidity & Mortality Weekly Report Vol. 62; no. 23; pp. 463 - 466 |
|---|---|
| Format: | Journal Article |
| Published: |
Centers for Disease Control & Prevention (CDC)
6/14/2013
|
| Online Access: | View this record in EBSCOhost |